Advancements in artificial intelligence, genomics, wearable technology, and regenerative medicine are transforming cardiovascular care from a reactive to a proactive and personalized approach.
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, necessitating continuous advancements in research and clinical practice. Research advancements have significantly transformed our understanding and management of CVDs. Recent breakthroughs in genomics, artificial intelligence (AI), wearable technology, and regenerative medicine are reshaping cardiovascular (CV) care. This review explores key innovations that bridge the gap between research and clinical application, emphasizing precision medicine, early detection, and personalized therapies. We also discuss challenges in implementation and future directions for optimizing CV outcomes.
Prabhash Chand Manoria (Tue,) conducted a review in Cardiovascular diseases. Cardiovascular care innovations (AI, genomics, wearables, regenerative medicine) was evaluated. Advancements in artificial intelligence, genomics, wearable technology, and regenerative medicine are transforming cardiovascular care from a reactive to a proactive and personalized approach.